Head and Neck Cancer Clinical Trial
Official title:
Nutritional Assessment of Locally Advanced Head and Neck Cancer Patients Who Underwent Exclusive or Adjuvant Radiotherapy or Chemo-radiotherapy
Radiotherapy and chemotherapy are standard treatment of head and neck cancer alone or associated to surgical treatment. Early (during treatment or the following weeks) and late side effects contribute to malnutrition in this population at risk. In this context, nutritional support adapted by dietary monitoring and enteral nutrition (nasogastric tube or gastrostomy) are often necessary. The early identification of the patients with high malnutrition risk and requiring enteral nutrition is necessary to improve the tolerance and efficacy of treatment. This prospective study research the factors of malnutrition during head and neck radiotherapy.
Head and neck cancer is one of the most common malignancies in the world, Malnutrition occurs
frequently at the time of diagnosis as consequences of alcohol consumption and tobacco use
that is quite common in this patients population, and of local tumor invasion, obstructing
the function of swallowing and chewing. In addition, during the treatment, mucositis,
anorexia, dysphagia, mouth sores, and other acute and late toxic effects of radiotherapy (RT)
and chemotherapy frequently worsen the nutritional status.
Poor nutritional status and chemotherapy or RT-toxicity, lead to treatment interruption
frequently and is also associated with higher risk of infection, hospital readmission, early
death, worse survival outcomes, and deterioration in the quality of life (QoL). According to
published results, one third of the patient would have benefit from a complete treatment. In
addition, the correlation exists between some biological parameters (CRP, albumin,
neutrophils, Hb) and the nutritional status. Therefore, it deems essential to maintain
nutritional status in head and neck cancer patients undergoing RT and chemotherapy.
Dietary counseling and oral supplements showed positive influences on nutritional outcomes
and QoL However, their role is limited when it comes to obstruction or mucositis. Thus,
enteral feeding may be a choice either through nasogastric tube (NGT) or percutaneous
endoscopic gastrostomy (PEG). Studies investigated the effects of PEG compared with NGT were
not conclusive or showing no consistent results on nutritional status, treatment
interruption, nutrition-related hospital admission, and tube-related complications in the
head and neck cancer patients receiving RT or chemo-radiotherapy.
The optimal method and the timing of placement are still debated. Consequently, the aim of
this study is to collect data on our current daily practice on supplementary nutrition method
( NGT, PEG) in head and neck cancers patients treated in our radiation therapy unit and to
identify factors predicting good treatment outcomes( ie full treatment administration).
Secondary objectives are to collect nutritional data during the treatment, to study the
nutritional status in relation to acute or late adverse events, to study the impact of an
early enteral feeding on clinical and biological parameters.
Ancillary study: Sarco-Nutrineck The aim of this ancillary study is to collect data on
prevalence of low muscle mass in this population, treatment outcomes and survival.
Study measures:
At baseline: body height and weight, calculated BMI. Biological parameters: albumin,
orosomucoid, transthyretin, CRP Daily - during the treatment period: weight Weekly - during
the treatment period: albumin, orosomucoid, transthyretin, CRP. The Nutritional and
inflammatory status score will be calculated.
Clinical criteria on the requirement of enteral nutrition (or need for artificial nutrition)
in case of weight loss persisting at least for three days during radiotherapy:
The aim of this study is to investigate whether nutritional screening on admission can be
used to determine risk levels for adverse clinical events and treatment outcome ( full
treatment administration) in head and neck cancer and to propose a risk stratification based
on nutritional screening before radiotherapy or concomitant chemo radiotherapy.
tube (NGT) will be placed according to the following procedure: The weight will be assessed
on daily basis and will be compared to the figure at baseline, before treatment. If the
weight loss is superior to 2 kg, the patient will consult a radiotherapist who will perform a
physical examination, a nutritional assessment (history, appetite change, taste, quantity and
quality of oral food intake, medication, details regarding weight change and BMI). In
addition to dietary counselling and oral supplementation, If indicated, analgesic drugs and
or treatment of associated mucositis will be prescribed.
In case of persisting weight loss or severe dysphagia or no oral solid food intake, a
nasogastric tube (NGT) will be placed by a nurse and a personalized nutritional counselling
by a dietician will be organized.
Biological exams will be done according to our local practice and standard, and the results
will be analyzed to assess the safety. Regular clinical exams will be realized. All adverse
events will reported according to the common terminology criteria for adverse events scale.
Follow-up period. The patients will benefit from a clinical exam, height, weight, BMI,
biological exam (including albumin, orosomucoid, transthyretin, CRP) one month after the end
of the treatment, and then at three months and at twelve months, late toxicities will be
recorded.
The aim of this study is to investigate whether nutritional screening on admission can be
used to determine risk levels for adverse clinical events and treatment outcome (full
treatment administration) in head and neck cancer and to propose i) isk stratification based
on nutritional screening before radiotherapy or concomitant chemo radiotherapy ii) decisional
algorithm on placement of a NGT
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05808920 -
The RESCUE Study: Survival and Functional Outcomes Following Salvage Surgery for RESidual or reCurrent sqUamous cEll Carcinoma of the Head and Neck
|
||
Completed |
NCT02526017 -
Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers
|
Phase 1 | |
Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT03997643 -
Preservation of Swallowing in Respected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial
|
Phase 2 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT04700475 -
Effect of Low Level Laser Therapy on Prevention of Radiotherapy Induced Xerostomia in Cancer Patients.
|
N/A | |
Withdrawn |
NCT04058145 -
AMD3100 Plus Pembrolizumab in Immune Checkpoint Blockade Refractory Head and Neck Squamous Cell Carcinoma
|
Phase 2 | |
Completed |
NCT02572869 -
Functional and Aesthetic Outcomes After Mandible Reconstruction With Fibula Osteomyocutaneous Free Flaps
|
||
Active, not recruiting |
NCT04474470 -
A Study to Evaluate NT219 Alone and in Combination With ERBITUX® (Cetuximab) in Adults With Advanced Solid Tumors and Head and Neck Cancer
|
Phase 1/Phase 2 | |
Withdrawn |
NCT05073809 -
Photoacoustic Imaging of Head and Neck Tumours
|
||
Active, not recruiting |
NCT04383210 -
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
|
Phase 2 | |
Active, not recruiting |
NCT03651570 -
Randomized Controlled Trial of a E-intervention to Help Patients Newly Diagnosed With Cancer Cope Better: Pilot Study
|
N/A | |
Recruiting |
NCT04930432 -
Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06016699 -
Immunological Function After Radiation With Either Proton or Photon Therapy
|
||
Terminated |
NCT03843554 -
Commensal Oral Microbiota in Head and Neck Cancer
|
N/A | |
Recruiting |
NCT05915572 -
Mulligan Technique on Shoulder Dysfunction
|
N/A | |
Completed |
NCT05897983 -
Tens and Rocabado Exercises on TMJ Dysfunction
|
N/A | |
Not yet recruiting |
NCT06289049 -
Heavy Strength Training in Head and Neck Cancer Survivors
|
Phase 2 | |
Withdrawn |
NCT05263648 -
Virtual Reality Software to Reduce Stress in Cancer Patients
|
N/A | |
Withdrawn |
NCT03238638 -
A Study of Epacadostat + Pembrolizumab in Head and Neck Cancer Patients, Who Failed Prior PD-1/PD-L1 Therapy
|
Phase 2 |